ES71
TEAS SECTION 71 RECEIVED
07/28/2026
Back to search
Official data from USPTO
ADHEXPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ADHEXPHARMA
ST13
US500000079238019Class
1, 3, 5, 10, 42
Filing
79238019
Registration
5969642
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
07/29/2026
Trademark type
Word
Nice classes
1, 3, 5, 10, 42
Filing date
05/09/2018
Registration date
01/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/28/2020
Last transaction
07/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Luxembourg, LU
Examiner
BROWN, TRICIA
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
B. E. (pessoa física)
Representatives
Mary Margaret L. O'Donnell BLUE FILAMENT LAW PLLC
Technical classification
Nice Classes
Class 1Class 3Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Adhesives for use in industry; adhesives for industrial use intended for the manufacture of transdermal patchessurgical bandagesdressingselectrodesdiagnostic devices and medical devices; adhesives for industrial use intended for the manufacture of cosmetic products; chemical preparations and biological compounds in the nature of biological preparations for industrial use intended for the manufacture of adhesivesdrugspharmaceutical patchesorally disintegrating filmsoral adhesive filmssublingual filmsdiagnostic devices and medical devices; chemical preparations and biological compounds in the nature of biological preparations for industrial use intended for the manufacture of cosmetic patches; chemical and biological compoundspharmaceutical and cosmetic active ingredientsall for industrial use in the nature of active chemical ingredients intended for the manufacture of pharmaceuticals and cosmetic pillscapsulespowderlotionpatchesdressings
Class 3
Patches and wipes impregnated with cosmeticspatches containing skin lotion and pre-moistened cosmetic wipes; cosmetic creams and masks
Class 5
Dressings articlesbandages in liquid form and in the form of gels in the nature of antiseptic liquid bandages and bandages for skin wounds; non-adherent medicated compresses and hydrogels for medical use; dermatological pharmaceutical products and medicinal preparations for wound care; medicated compresses; adhesives for medical usemedical adhesive tape; adhesives for suturing woundsadhesive bandages; adhesive ribbons and films for pharmaceutical and medical useadhesive bandages; orodispersible films for pharmaceutical and medical usedrug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; oral adhesive films and sublingual films for pharmaceutical or medical usedrug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; transdermal patches facilitating the delivery of pharmaceutical active ingredients or pharmaceutical preparations into the skin and into the bloodstream featuring preparations for the treatment of pain and diseases and disordersof the skeletalmuscularnervousendocrineimmunecirculatoryhematologicalcardiovascularcardiopulmonarylymphaticrespiratorydigestivegenitourinaryurinaryreproductivepsychiatricmetaboliconcologicalhepatologicalophthalmicneurologicalgastrointestinalhormonal and integumentary systems; medicated creams for treating dermatological conditions; medical diagnostic test media in the form of patches in the nature of strips for measuring blood analysisurine analysissaliva analysisdermatological analysis; adhesives for surgicaldental or medical useadhesive plasters for medical purposes
Class 10
Suture materials; surgical sterile sheets; drainage tubes for medical use; pressure orthopedic support bandages; blood collection bags for medical use; electrodes for medical use; diagnostic apparatus for medical use for testing blood sugar levelsbody temperatureheart pulsationbreathing capacityblood pressuremolecular oxygen concentrationDNAcancer cells; apparatus for the administration of medicinal substancesinfusion and injection devices for administering drugs; tubing for medical use for administering medicines; medical apparatus to introduce pharmaceutical preparations into the body; implantable medical devices for the subcutaneous release of medicinal substancesimplantable subcutaneous drug delivery devices sold empty; droppers for medical purposesdroppers for administering medicationsold empty
Class 42
Medical research; design and development of medical technologiestechnology research in the field of medical instruments and devicesmedical adhesives and patchesmedical oral thin films; scientific research and development services; scientific research and development in the medical sector; medical research laboratory services; development of pharmaceutical preparations and medicines; pharmaceutical research servicesanalytical and industrial research services for the manufacture of pharmaceuticals and medicines
Publications
History of USPTO decisions and trademark events.
49 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/28/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/26/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/22/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/06/2020
FIMP
FINAL DISPOSITION PROCESSED
05/06/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/28/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
01/28/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/24/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/08/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2019
PUBO
PUBLISHED FOR OPPOSITION
11/12/2019
GPNX
NOTIFICATION PROCESSED BY IB
11/08/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/23/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/23/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2019
ALIE
ASSIGNED TO LIE
10/10/2019
EXPT
EXPARTE APPEAL TERMINATED
10/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/09/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
10/09/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/09/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
10/09/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/09/2019
EXPI
EX PARTE APPEAL-INSTITUTED
09/20/2019
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
09/20/2019
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
09/20/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2019
ALIE
ASSIGNED TO LIE
08/29/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/23/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/21/2019
GNFR
FINAL REFUSAL E-MAILED
03/21/2019
CNFR
FINAL REFUSAL WRITTEN
03/21/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/05/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/05/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/29/2018
RFNT
REFUSAL PROCESSED BY IB
09/29/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/11/2018
RFRR
REFUSAL PROCESSED BY MPU
09/11/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/04/2018
CNRT
NON-FINAL ACTION WRITTEN
09/03/2018
DOCK
ASSIGNED TO EXAMINER
08/30/2018
MAFR
APPLICATION FILING RECEIPT MAILED
08/11/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/02/2018
Continuous trademark protection
Get notified about every new filing that threatens ADHEXPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.